Fecal Microbiota Transplant (FMT) for Gut Health: Evidence, Approvals, and What to Know
At a Glance FMT involves transferring stool from a healthy screened donor into a patient’s gut to restore a disrupted microbiome. It works dramatically well for recurrent C. difficile infection, with cure rates above 90%. The FDA approved the first FMT product, Vowst (SER-109), in 2023 for recurrent C. diff. A second product, Rebyota, was…









